Journal
CURRENT MEDICINAL CHEMISTRY
Volume 27, Issue 36, Pages 6136-6158Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/0929867326666190712165444
Keywords
GnRH; GnRH receptor; infertility; prostate cancer; ovarian cancer; agonists; antagonists
Funding
- State Scholarships Foundation (IKY) through Post-doctoral Financial Support action part of the Development of Human Resources, Education and Life-long learning action
- Hellenic Republic [MIS 5001552]
- European Social Fund
Ask authors/readers for more resources
Background: Gonadotropin-Releasing Hormone (GnRH) is a key element in sexual maturation and regulation of the reproductive cycle in the human organism. GnRH interacts with the pituitary cells through the activation of the Gonadotropin Releasing Hormone Receptors (GnRHR). Any impairments/dysfunctions of the GnRH-GnRHR complex lead to the development of various cancer types and disorders. Furthermore, the identification of GnRHR as a potential drug target has led to the development of agonist and antagonist molecules implemented in various treatment protocols. The development of these drugs was based on the information derived from the functional studies of GnRH and GnRHR. Objective: This review aims at shedding light on the versatile function of GnRH and GnRH receptor and offers an apprehensive summary regarding the development of different agonists, antagonists and non-peptide GnRH analogues. Conclusion: The information derived from these studies can enhance our understanding of the GnRH-GnRHR versatile nature and offer valuable insight into the design of new more potent molecules.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available